All Stories

  1. Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis
  2. The “dilemma of double lifelines”: central venous catheter co-existence with transvenous cardiac pacemaker
  3. Impact of pre and post transplant 25(OH) Vit-D levels on graft function in living related kidney transplant recipients
  4. Should patients with chronic active antibody mediated rejection be treated with plasmapheresis and intravenous immunoglobulin?
  5. Treatment and outcomes of HCV infected post transplant recipients with direct acting anti-viral agents
  6. FGF23 is associated with early post-transplant hypophosphataemia and normalizes faster than iPTH in living donor renal transplant recipients: a longitudinal follow-up study
  7. Safety and Effectiveness of Response-Guided Therapy Using Pegylated Interferon and Ribavirin for Chronic Hepatitis C Virus Infection in Patients on Maintenance Dialysis
  8. Chapter-53 Hemodialysis
  9. Chapter-21 Tunneling of Central Venous Catheter
  10. De-novo donor-specific antibody (DSA) against HLA-DQ antigens resulting in acute antibody mediated rejection in a renal transplant patient
  11. Fibroblast growth factor-23, vitamin D and mineral metabolism in renal transplant recipients
  12. Urinary Kidney injury molecule-1 can predict delayed graft function in living donor renal allograft recipients
  13. Renal transplant: Tacrolimus use and two weeks post-transplant serum creatinine levels predict early acute rejections
  14. Childhood lupus with microangiopathic antiphospholipid syndrome and pulmonary hemorrhage
  15. Ten years graft and patient outcomes of renal allograft recipients with VEGF gene polymorphisms
  16. Initial experience of sofosbuvir treatment in HCV infected renal transplant recipient
  17. Ten years outcomes of HCV positive renal allograft recipients is not inferior than that of HCV negative patients
  18. Rhizobium radiobacter peritonitis: the first case report from India and review
  19. The many faces of infection in a hemodialysis patient
  20. Lack of persistent hepatitis E virus infection as a cause for unexplained transaminase elevation in renal transplant recipients in India
  21. Outcomes of living donor renal transplant recipients with and without basiliximab induction: A long-term follow-up study
  22. Do the outcomes of living donor renal allograft recipients differ with peritoneal dialysis and hemodialysis as a bridge renal replacement therapy?
  23. Evaluation of efficacy of fluoxetine in the management of major depression and arthritis in patients of Rheumatoid Arthritis
  24. The role of genetics in hypertension
  25. Outcomes of De Novo Allograft Diabetic Nephropathy in Renal Allograft Recipients
  26. Renal phosphate handling: Physiology
  27. Septic acute kidney injury in critically ill Indian patients
  28. Uremic myopathy
  29. Nonsurgical management of hematuria following percutaneous biopsy of renal allograft
  30. Passenger lymphocyte syndrome exhibited in a renal transplant recipient: A case report
  31. Cytomegalovirus Disease in Renal Transplant Recipients: A Single-Center Experience
  32. Mechanism of hyperfiltration
  33. Pyogenic sacroiliitis in a renal allograft recipient
  34. Interventional management of post-transplant lymphocele
  35. Superior venacava syndrome presenting immediate post-renal transplantation
  36. A rare case of herpes zoster during disseminated varicella infection in renal allograft recipient
  37. Toxic acute kidney injury
  38. High anion gap refractory metabolic acidosis as a critical presentation of endosulfan poisoning